Last reviewed · How we verify
Placebo granule
Placebo granule is a Small molecule drug developed by Xiyuan Hospital of China Academy of Chinese Medical Sciences. It is currently in Phase 3 development. Also known as: Radiotherapy.
This drug is a placebo, meaning it has no active therapeutic effect.
Placebo granules are a type of intervention used in clinical studies, including those for Inflammatory Bowel Disease, Stroke, Critically Ill, IgA Nephropathy at High Risk of Developing ESRD, and Covid19. Placebo granules are a small molecule modality, classified as a type of intervention in clinical trials, but their exact mechanism of action is not specified in the provided information.
-
Baseline phase 3 → approval rate
+58.3pp
Industry-wide phase 3 drugs reach approval ~58.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2028–2030 | — |
| EMA | EU | 2029–2031 | +0.7 yr |
| MHRA | GB | 2029–2031 | +0.7 yr |
| Health Canada | CA | 2029–2032 | +0.9 yr |
| TGA | AU | 2029–2032 | +1.2 yr |
| PMDA | JP | 2029–2032 | +1.5 yr |
| NMPA | CN | 2030–2033 | +2.3 yr |
| MFDS | KR | 2029–2032 | +1.4 yr |
| CDSCO | IN | 2029–2033 | +1.8 yr |
| ANVISA | BR | 2030–2033 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Placebo granule |
|---|---|
| Also known as | Radiotherapy |
| Sponsor | Xiyuan Hospital of China Academy of Chinese Medical Sciences |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not interact with any biological molecules or systems, and its effects are purely psychological or due to the natural course of the disease.
Approved indications
Common side effects
Key clinical trials
- Pivotal Study of N-acetyl-L-leucine for CACNA1A (PHASE3)
- Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty (EARLY_PHASE1)
- Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis (PHASE2)
- Clinical Study on Guben Kechuan Granules Promoting Disease Recovery by Regulating Immune-Inflammatory Dysregulation in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease During the Peri-Discharge Period (NA)
- Racecadotril for Organ Injury in Sepsis Patients (PHASE1, PHASE2)
- PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia (PHASE1, PHASE2)
- Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection (PHASE2)
- A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo granule CI brief — competitive landscape report
- Placebo granule updates RSS · CI watch RSS
- Xiyuan Hospital of China Academy of Chinese Medical Sciences portfolio CI
Frequently asked questions about Placebo granule
What is Placebo granule?
How does Placebo granule work?
Who makes Placebo granule?
Is Placebo granule also known as anything else?
What development phase is Placebo granule in?
Related
- Manufacturer: Xiyuan Hospital of China Academy of Chinese Medical Sciences — full pipeline
- Also known as: Radiotherapy
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing